Neuropeptides in psoriasis: possible role of beta-endorphin in the pathomechanism of the disease

Int J Dermatol. 1994 May;33(5):356-60. doi: 10.1111/j.1365-4362.1994.tb01068.x.

Abstract

Background: An increased concentration of neuropeptides in psoriatic lesional skin may be responsible for alterations in the neurogenic erythematous response and transmission of stimuli through sensory nerve fibers (sensation of pruritus).

Methods: Increasing doses of capsaicin from 0.125 to 4 micrograms/cm2 were applied to nonlesional psoriatic skin to establish the minimal dose that induced the substance P-mediated neurogenic response in 30 patients with psoriasis. Plasma beta-endorphin was quantitated in 71 psoriatics by radioimmunoassay using NEN 1251-RIA kit.

Results: The mean beta-endorphin concentration was increased about 2-fold compared to normals, whereas doses of capsaicin needed to induce erythema were higher (1-4 micrograms/cm2) in psoriatics (mainly in patients with type II psoriasis) than in healthy subjects (0.125-0.25 microgram/cm2).

Conclusions: The data indicate that increased beta-endorphin in psoriatic skin might affect both substance P-mediated neurogenic inflammation and transmission of sensory stimuli due to local antinociceptive effects of this opioid. The differences in the neurogenic response in type I and II psoriasis may be related to the degradation of substance P and beta-endorphin by neutral proteinases in the lesional skin.

MeSH terms

  • Capsaicin / pharmacology
  • Dermatitis, Atopic / blood
  • Humans
  • Neuropeptides / physiology
  • Psoriasis / etiology
  • Psoriasis / metabolism*
  • Scleroderma, Systemic / blood
  • Skin / metabolism
  • Substance P / physiology
  • beta-Endorphin / blood
  • beta-Endorphin / physiology*

Substances

  • Neuropeptides
  • Substance P
  • beta-Endorphin
  • Capsaicin